UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30June 30, 201207

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                        

 

Commission File Number 0-20191

 

INTRUSION INC.

(Exact name of registrant as specified in its charter)

 

Delaware

75-1911917

(State or other jurisdiction of

(I.R.S. Employer


incorporation or organization)

(I.R.S. Employer
Identification No.)

 

1101 East Arapaho Road, Suite 200, Richardson, Texas 75081

(Address of principal executive offices)

(Zip Code)

 

(972) 234-6400

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

* * * * * * * * * *

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

           

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large“large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

(Do not check if a smaller reporting company)

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)Act): Yes ☐ No ☒

 

The number of shares outstandingoutstanding of the Registrant’s Common Stock, $0.01 par value, on November 1, 2017July 31, 2020 was 12,797,836.13,792,030.

 



 


1

 

 

INTRUSION INC.

 

INDEX

 

PART I – FINANCIAL INFORMATION

 
  

Item 1. Financial Statements

3
  

Unaudited Condensed Consolidated Balance Sheets as of SeptemberJune 30, 20172020 and December 31, 2016

2019
3
  

Unaudited Condensed Consolidated Statements of Operations for the three and ninesix months ended SeptemberJune 30, 20172020 and 20162019

4
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the six months ended June 30, 2020 and 20195
  

Unaudited Condensed Consolidated Statements of Cash Flows for the ninesix months ended SeptemberJune 30, 20172020 and 2016

5

Notes to Unaudited Condensed Consolidated Financial Statements2019

6
  

Notes to Unaudited Condensed Consolidated Financial Statements

7
Item 2. Management’sManagement’s Discussion and Analysis of Financial Condition and Results of Operations

9

Item 4. Controls and Procedures

12

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

13
  

Item 1A. Risk Factors

4. Controls and Procedures
1316
  

Item 6. Exhibits

PART II – OTHER INFORMATION
1516
  

Item 1. Legal Proceedings

16
Item 1A. Risk Factors17
Item 6. Exhibits19
Signature Page

1620

 


2

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. FINANCIAL STATEMENTS

 

INTRUSION INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value amounts)

 

 

September 30,

2017

  

December 31,
2016

  

June 30,

2020

  

December 31,
2019

 

ASSETS

                

Current Assets:

                

Cash and cash equivalents

 $263  $64  $2,872  $3,334 

Accounts receivable

  879   745   1,067   1,566 

Inventories

  30   45 

Prepaid expenses

  37   75   388   152 

Total current assets

  1,209   929   4,327   5,052 

Noncurrent Assets:

        

Property and equipment, net

  162   308   311   335 

Finance leases, right-of-use assets, net

  41   62 

Operating leases, right-of-use asset, net

  1,223   1,348 

Other assets

  38   40   36   38 

Total noncurrent assets

  1,611   1,783 

TOTAL ASSETS

 $1,409  $1,277  $5,938  $6,835 
                

LIABILITIES AND STOCKHOLDERS’ DEFICIT

        

LIABILITIES AND STOCKHOLDERS’ EQUITY

        
                

Current Liabilities:

                

Accounts payable and accrued expenses

 $1,060  $896  $1,152  $1,080 

Dividends payable

  411   303   19   20 

Obligations under capital lease, current portion

  70   139 

Finance leases liability, current portion

  38   43 

Operating leases liability, current portion

  291   284 

PPP loan payable, current portion

  285    

Deferred revenue

  658   395   164   516 

Total current liabilities

  2,199   1,733   1,949   1,943 
        

Loan payable to officer

  2,865   2,885 

Obligations under capital lease, noncurrent portion

  22   61 

Noncurrent Liabilities:

        

Finance leases liability, noncurrent portion

  5   21 

Operating leases liability, noncurrent portion

  1,170   1,315 

PPP loan payable, noncurrent portion

  345    

Total noncurrent liabilities

  1,520   1,336 
                

Commitments and contingencies

                

Stockholders’ deficit:

        
     

Stockholders’ equity:

        

Preferred stock, $0.01 par value: Authorized shares – 5,000

                

Series 1 shares issued and outstanding — 200 Liquidation preference of $1,150 in 2017 and $1,113 in 2016

  707   707 

Series 2 shares issued and outstanding — 460 Liquidation preference of $1,313 in 2017 and $1,270 in 2016

  724   724 

Series 3 shares issued and outstanding — 289 Liquidation preference of $720 in 2017 and $697 in 2016

  412   412 

Series 1 shares issued and outstanding — 200 Liquidation preference of $1,012 in 2020 and $1,013 in 2019

  707   707 

Series 2 shares issued and outstanding — 420 in 2020 and 460 in 2019 Liquidation preference of $1,054 in 2020 and $1,155 in 2019

  661   724 

Series 3 shares issued and outstanding — 266 in 2020 and 289 in 2019 Liquidation preference of $583 in 2020 and $634 in 2019

  379   412 

Common stock, $0.01 par value:

                

Authorized shares — 80,000

                

Issued shares — 12,808 in 2017 and 12,758 in 2016 Outstanding shares — 12,798 in 2017 and 12,748 in 2016

  128   128 

Issued shares — 13,802 in 2020 and 13,552 in 2019 Outstanding shares — 13,792 in 2020 and 13,542 in 2019

  138   136 

Common stock held in treasury, at cost – 10 shares

  (362

)

  (362

)

  (362

)

  (362

)

Additional paid-in capital

  56,541   56,595   56,946   56,759 

Accumulated deficit

  (61,720

)

  (61,499

)

  (55,957

)

  (54,777

)

Accumulated other comprehensive loss

  (107

)

  (107

)

  (43

)

  (43

)

Total stockholders’ deficit

  (3,677

)

  (3,402

)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

 $1,409  $1,277 

Total stockholders’ equity

  2,469   3,556 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 $5,938  $6,835 

 

See accompanying notes.

 


3

 

 

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)

 

 

Three Months Ended

  

Nine Months Ended

  

Three Months Ended

  

Six Months Ended

 
 

September 30, 2017

  

September 30, 2016

  

September 30, 2017

  

September 30, 2016

  

June 30, 2020

  

June 30, 2019

  

June 30, 2020

  

June 30, 2019

 

Revenue

 $1,678  $1,595  $4,780  $4,693  $1,655  $4,020  $3,450  $7,211 

Cost of revenue

  736   610   1,951   1,677   651   1,590   1,398   2,874 
                                

Gross profit

  942   985   2,829   3,016   1,004   2,430   2,052   4,337 
                                

Operating expenses:

                                

Sales and marketing

  394   429   1,169   1,276   485   46   995   458 

Research and development

  617   508   1,797   1,908   907   296   1,660   477 

General and administrative

  242   292   855   941   326   321   582   652 
                                

Operating loss

  (311

)

  (244

)

  (992

)

  (1,109

)

Operating income (loss)

  (714

)

  1,767   (1,185

)

  2,750 
                                

Other Income

  928      928    

Interest expense, net

  (49

)

  (36

)

  (157

)

  (102

)

Interest income

  1      7    

Interest expense

  (2

)

  (9

)

  (2

)

  (44

)

                                

Net Income (loss)

 $568  $(280

)

 $(221

)

 $(1,211

)

Net income (loss)

 $(715

)

 $1,758  $(1,180

)

 $2,706 
                                

Preferred stock dividends accrued

  (35

)

  (35

)

  (104

)

  (104

)

  (33

)

  (35

)

  (66

)

  (69

)

Net income (loss) attributable to common stockholders

 $533  $(315

)

 $(325

)

 $(1,315

)

 $(748

)

 $1,723  $(1,246

)

 $2,637 
                                

Net income (loss) per share attributable to common stockholders:

                                

Basic

 $0.04  $(0.02

)

 $(0.03

)

 $(0.10

)

 $(0.05

)

 $0.13  $(0.09

)

 $0.20 

Diluted

 $0.04  $(0.02

)

 $(0.03

)

 $(0.10

)

 $(0.05

)

 $0.11  $(0.09

)

 $0.17 
                                

Weighted average common shares outstanding:

                        

Basic

  12,798   12,748   12,781   12,733   13,784   13,523   13,743   13,466 

Diluted

  14,076   12,748   12,781   12,733   13,784   15,371   13,743   15,314 

 

See accompanying notes.

 


4

INTRUSION INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(In thousands)

  

Six Months Ended

 
  

June 30, 2020

  

June 30, 2019

 

NUMBER OF PREFERRED SHARES—ISSUED AND OUTSTANDING

        

Balance, beginning of quarter

  949   949 

Conversion of preferred stock to common

  (63

)

   

Balance, end of quarter

  886   949 

PREFERRED STOCK

        

Balance, beginning of quarter

 $1,843  $1,843 

Conversion of preferred stock to common

  (96

)

   

Balance, end of quarter

  1,747   1,843 

NUMBER OF COMMON SHARES—ISSUED

        

Balance, beginning of quarter

  13,552   13,259 

Conversion of preferred stock to common

  63    

Exercise of stock options

  187   280 

Balance, end of quarter

  13,802   13,539 

COMMON STOCK

        

Balance, beginning of quarter

 $136  $133 

Conversion of preferred stock to common

  1    

Exercise of stock options

  1   2 

Balance, end of quarter

 $138  $135 

TREASURY SHARES

        

Balance, beginning of quarter and end of quarter

 $(362

)

 $(362

)

ADDITIONAL PAID-IN-CAPITAL

        

Balance, beginning of quarter

 $56,759  $56,609 

Conversion of preferred stock to common

  95    

Stock-based compensation

  74   14 

Exercise of stock options

  84   224 

Preferred stock dividends declared, net of waived penalties by shareholders

  (66

)

  (62

)

Balance, end of quarter

 $56,946  $56,785 

ACCUMULATED DEFICIT

        

Balance, beginning of quarter

 $(54,777

)

 $(59,242

)

Net income (loss)

  (1,180

)

  2,706 

Balance, end of quarter

 $(55,957

)

 $(56,536

)

ACCUMULATED OTHER COMPREHENSIVE LOSS

        

Balance, beginning of quarter and end of quarter

 $(43

)

 $(43

)

TOTAL STOCKHOLDERS’ EQUITY

 $2,469  $1,822 

See accompanying notes.

5

 

 

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

 

 

Nine Months Ended

  

Six Months Ended

 
 

September 30,

2017

  

September 30,
201
6

  

June 30,

2020

  

June 30,
201
9

 

Operating Activities:

                

Net loss

 $(221) $(1,211

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

        

Net income (loss)

 $(1,180

)

 $2,706 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

        

Depreciation and amortization

  159   218   107   86 

Stock-based compensation

  16   82   74   14 

Penalties and waived penalties on dividends

  24   13 

Gain on sale of investment

  (56

)

   

Penalties on dividends

     6 

Noncash lease costs

  124   304 

Changes in operating assets and liabilities:

                

Accounts receivable

  (134

)

  (8

)

  499   (738

)

Inventories

  15   (7

)

Prepaid expenses and other assets

  40   30   (234

)

  (234

)

Accounts payable and accrued expenses

  168   41   (64

)

  (66)

Deferred revenue

  263   236   (352

)

  179 

Net cash provided by (used in) operating activities

  274   (606

)

  (1,026

)

  2,257 
                

Investing Activities:

                

Purchases of property and equipment

  (13

)

  (41

)

�� (62

)

  (168

)

Proceeds from sale of investment

  56    

Net cash provided by (used by) investing activities

  43   (41

)

                

Financing Activities:

                

Proceeds from line of credit

     364 

Payments on line of credit

     (364

)

Proceeds from stock options exercised

  11   99 

Borrowings on loans from officer

  1,580   805 

Payments on loans from officer

  (1,600

)

   

Principal payments on capital leases

  (109

)

  (149

)

Net cash provided by (used by) financing activities

  (118

)

  755 

Proceeds from PPP loan payable

  629    

Payments on loan from officer

     (1,815

)

Proceeds from stock options exercised

  85   226 

Payments of dividends

  (67

)

  (644

)

Reduction of finance lease liability

  (21

)

  (31

)

Net cash provided by (used in) financing activities

  626   (2,264

)

                

Net increase in cash and cash equivalents

  199   108 

Net decrease in cash and cash equivalents

  (462

)

  (175

)

Cash and cash equivalents at beginning of period

  64   102   3,334   1,652 

Cash and cash equivalents at end of period

 $263  $210  $2,872  $1,477 
        
                

SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:

                
                

Preferred stock dividends accrued

 $104  $104  $66  $68 

Purchase of leased equipment under capital lease

 $  $6 

Conversion of preferred stock to common

 $96  $ 

 

See accompanying notes.

 


6

 

INTRUSION INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

1.

1.Description of Business

 

We develop, market and support a family of entity identification, high speed data mining cybercrimeand cybersecurity solutions. Our products help detect, report and mitigate cybercrimes and advanced persistent threat detection products. threats.

Our product families include:

 

 

TraceCop™TraceCop for identity discoveryentity identification, cybercrime detection and disclosure, and;

 

Savant™Savant for networkhigh speed data mining, analytics, detection, reporting and advanced persistent threat detection.mitigation of cybersecurity threats.

Our products in development include:

Intrusion Shield

        We are in the process of developing a new product offering, Intrusion Shield, that is designed to be a next generation intrusion detection and protection solution.  After 20 years of providing research, analysis, and tools to the federal government and enterprise corporations, Intrusion possesses a comprehensive and proprietary database of Internet activity, including information about the activities of malicious online actors.  Intrusion’s Shield product will combine that comprehensive database with artificial intelligence (AI) and real-time process flow technology to provide businesses and government agencies with a unique and affordable tool to detect, identify, and prevent cyber-crimes. 

Shield is a combination of plug-and-play hardware, software, global data, and AI services providing organizations with aggressive protection against unaddressed information security threats and the most robust defense possible against cybercrime. Unlike traditional industry approaches that rely heavily on human resources, which malicious actors have learned to bypass, Intrusion Shield uses our extensive database together with real-time AI technology to prevent illicit behavior.  Shield's proprietary architecture isolates and neutralizes malicious traffic and network flows that existing solutions cannot identify or even characterize. Most breaches today are caused by malware free compromises that trigger no alarms in a firewall or endpoint solution. The common denominator is network communications, and Shield monitors and analyses all network traffic and communications allowing it to identify and stop malware-free attacks. Shield's capabilities will continuously evolve based on real-time updates originating from our worldwide installations and growing TraceCop database identifying new dangers.

Shield does not seek to displace existing solutions, instead providing a new, and additional layer of cybersecurity for enterprises.  According to SBA 2019, the U.S. enterprise market consists of 30.7 million businesses, of which 70% are characterized as small and medium sized businesses.  While the company believes that many large enterprises will recognize the need this product addresses and will be incentivized to purchase Shield, the enterprise market has many decision makers for new security product purchases; therefore, the sale cycle may be longer for this product than our current product offerings.  We have identified businesses with from 100 to 1,000 users as our initial target market, as we believe this market segment has the most pressing need for the enhanced protection that the Intrusion Shield will offer.  We intend to leverage existing and new channel partners, such as value added resellers and systems integrators, to market Shield to this target market.

Shield has experienced positive progress during Alpha testing and the Company has identified twelve companies for the Beta release anticipated to begin in September.  The configuration of hardware is a single Dell network appliance installed inline inside of the customer's firewall.  The size of the network appliance will vary depending on the number of workstations and the size of the customer's internet connection be that 1Gb, 10Gb, or 100 Gb.

Intrusion’s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.

 

We market and distribute our products through a direct sales force to:

 

 

end-users,

and
 

value-added resellers,

system integrators,

managed service providers, and

distributors.

resellers.

 

Our end-user customers include:

 

 

U.S. federal government entities,

 

state and local government entities,

 

banks,large and diverse conglomerates,

 

airlines,

credit unions,

other financial institutions,

hospitals and other healthcare providers,manufacturing entities, and

 

other customers.

 

Essentially, our end-users can be defined as any end-users requiring network security solutions for protecting their mission critical data.

7

 

We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400.(972) 234-6400. Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. TraceCop and Savant are trademarksTrademarks of Intrusion Inc.include:

INTRUSION SHIELD

PROCESS FLOW TECHNOLOGY

INTRUSION SAVANT

BRINGING SCIENCE INTO DECISION MAKING

TRACECOP

INTRUSION PROTECT EVERYTHING. TRUST NOTHING

PROTECT EVERYTHING. TRUST NOTHING.

 

 

2.Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q10-Q and Item 10-0110-01 of Regulation S-X.S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2016 2019 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three and ninesix month periods ended SeptemberJune 30, 2017, 2020 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10-K10-K for the year ended December 31,2016, 2019, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 29, 2017.27, 2020.

 

The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest (see Note 4).interest.  Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.

 


In May2014, the FASB issued Accounting Standards Update No.2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes most current revenue recognition guidance under U.S. GAAP. The core principle ofOn January 1, 2019 we adopted ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. The standard is effective for us beginning 2018. We will be using the following transition method:  a modified retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized atNo. 2016-02, Leases (topic 842). At the date of adoption (which includes additional footnote disclosures). We do not believethere was no impact on the adoptionstatement of this guidance willoperations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU No. 2016-02 did not have a material impacteffect on our financial statements.the Company’s results of operations or cash flows for the three and six month periods ended June 30, 2020 and 2019.

 

 

3.Inventories (In thousands)

  

September 30,
2017

  

December 31,
2016

 
         

Inventories consist of:

        

Finished products

  30   45 

Net inventory

 $30   45 

4.     Loan Payable to Officer

 

On February 9, 2017, 8, 2018, the Company entered into an unsecured revolving promissory note to borrow up to $3,400,000$3,700,000 from G. Ward Paxton, the Company’s Chief Executive Officer (the “CEO Note”).Paxton. Under the terms of the note,CEO Note, the Company may had the ability to borrow, repay and re-borrowreborrow on the loan as needed up to an outstanding principal balance due of $3,400,000$3,700,000 at any given time through March 2018.2020.

 

On March 2, 2017, February 7, 2019, the Company amended the unsecured revolving promissory note to borrow up to $2,700,000 from G. Ward Paxton, the Company’s former Chief Executive Officer. Amounts borrowed under the CEO Note described above on the same terms, with the Company being able to borrow, repay, and re-borrow on the note as needed up to an outstanding principal balance due of $3,700,000 at any given time through March 2019.

Amounts borrowed from this officer accrueaccrued interest at a floating rate per annum equal to Silicon Valley Bank’sBank’s (“SVB”) prime rate plus 1% (5.25%. Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,700,000 at September 30, 2017). All outstanding borrowings and accrued but unpaid interest is due on any given time through March 31,2021. We reduced our borrowing under this note to zero as of May 2019.

As of September 30, 2017, October 24, 2019, G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings outstanding totaled $2,865,000thereunder will no longer be available to the Company. Our management will be assessing whether to replace this borrowing capacity and accrued interest totaled $308,000.assessing what terms may be available to the Company, including whether any such terms are acceptable to the Company, if at all.

8

 

 

6.4.     Accounting for Stock-Based Compensation

 

During the three month periods ended SeptemberJune 30, 2017 2020 and 2016,2019, the Company did not grant anygranted 323,000 and 24,000, respectively, of stock options to employees or directors. The Company recognized $6,000$55,000 and $20,000,$10,000, respectively, of stock-based compensation expense for the three month periods ended SeptemberJune 30, 2017 2020 and 2016.2019. During the ninesix month periods ended SeptemberJune 30, 2017 2020 and 2016,2019, the Company granted 24,000323,000 and 24,000, respectively, of stock options to employees and directors. The Company recognized $16,000$74,000 and $82,000,$14,000, respectively, of stock-based compensation expense for the ninesix month periods ended SeptemberJune 30, 2017 2020 and 2016.2019.

 

During the three month periods ended SeptemberJune 30, 2017 2020 and 2016,no options2019, 14,000 and 14,000 were exercised under the 2005 Plan. Plan, respectively. During the ninesix month periods ended SeptemberJune 30, 2017 2020 and 2016,50,0002019, 186,600 and 136,000 options280,500 were exercised under the 2005 Plan, respectively.

 

Valuation Assumptions

 

The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

 

  

For Three

Months Ended

September 30, 2017

  

For Three

Months Ended

September 30, 2016

  

For Nine

Months Ended

September 30, 2017

  

For Nine

Months Ended
September 30, 2016

 
                 

Weighted average grant date fair value

  -   -  $0.26  $0.29 

Weighted average assumptions used:

                

Expected dividend yield

  -   -   0.0

%

  0.0

%

Risk-free interest rate

  -   -   1.77

%

  1.38

%

Expected volatility

  -   -   75.0

%

  96.0

%

Expected life (in years)

  -   -   5.0   5.0 


  

For Three Months Ended

June 30, 2020

  

For Three Months Ended

June 30, 2019

  

For Six Months

 Ended

June 30, 2020

  

For Six Months

Ended
June 30, 2019

 
                 

Weighted average grant date fair value

 $2.80  $3.61  $2.80  $3.61 

Weighted average assumptions used:

                

Expected dividend yield

  0.0

%

  0.0

%

  0.0

%

  0.0

%

Risk-free interest rate

  0.43

%

  2.19

%

  0.43

%

  2.19

%

Expected volatility

  76.00

%

  127.52

%

  76.00

%

  127.52

%

Expected life (in years)

  6.2   5.0   6.2   5.0 

 

Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.

 

 

7.5.     Revenue Recognition

We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do not currently offer software on a subscription basis. Warranty costs and sales returns have not been material.

We recognize sales of our data sets in accordance with FASB ASC Topic 606 whereby revenue from contracts with

customers is not recognized until all five of the following have been met:

i)

identify the contract with a customer;

ii)

identify the performance obligations in the contract;

iii)

determine the transaction price;

iv)

allocate the transaction price to the separate performance obligations; and

v)recognize revenue upon satisfaction of a performance obligation.

Data updates are typically done monthly and revenue will be matched accordingly. Product sales may include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We may defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally one year.

Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has not been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.

9

Our normal payment terms offered to customers, distributors and resellers are net 30 days domestically and net 45 days internationally. We do not offer payment terms that extend beyond one year and rarely do we extend payment terms beyond our normal terms. If certain customers do not meet our credit standards, we do require payment in advance to limit our credit exposure.

Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.

Contract assets represent contract billings for sales per contracts with customers and are classified as current. Our contract assets include our accounts receivables. At June 30, 2020, the Company had contract assets balance of $1,067,000. At December 31, 2019, the Company had contract assets balance of $1,566,000.

Contract liabilities consist of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies deferred revenue as a contract liability. At June 30, 2020, the Company had contract liabilities balance of $164,000. At December 31, 2019, the Company had contract liabilities balance of $516,000.

6.     Net LossIncome (Loss) Per Share

 

Basic net lossincome (loss) per share is computed by dividing net lossincome attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net lossincome (loss) per share is computed by dividing the net lossincome (loss) attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options and warrants.options. The aggregate number of common stock equivalents excluded from the diluted lossincome (loss) per share calculation for the three month periods ended SeptemberJune 30, 2017 2020 and 20162019 are 1,014,5001,942,990 and 3,532,943 as they are antidilutive.12,132, respectively. The aggregate number of common stock equivalents excluded from the diluted lossincome (loss) per share calculation for the ninesix month periods ended SeptemberJune 30, 2017 2020 and 20162019 are 1,675,6191,909,289 and 3,545,745 as they6,066, respectively. Since the Company is in a net loss position for the three and six month periods ending June 30, 2020, basic and dilutive net loss per share are antidilutive.the same.

 

 

8.7.     Concentrations

 

Our operations are concentrated in one area area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 90.6%91.0% of total revenues for the thirdsecond quarter of 20172020 compared to 78.4%91.3% of total revenues for the thirdsecond quarter of 2016.2019. During the thirdsecond quarter of 2017,2020, approximately 90.6%91.0% of total revenues were attributable to sixfour government customers compared to approximately 78.4%73.2% of total revenues attributable to fivethree government customers in the thirdsecond quarter of 2016. Sales to2019. In the second quarter of 2020, no individual commercial customers totaled 9.4%customer had revenues over 10.0% of total revenue compared to no individual commercial customer for the third quarter of 2017 compared to 21.6% of total revenue for the third quarter of 2016. During the third quarter of 2017, approximately 6.2% of total revenue was attributable to one commercial customer compared to approximately 18.9% to one commercial customersame period in the third quarter of 2016.2019. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.

 

 

9.8.     Commitments and Contingencies

 

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise in the future will not have such a material impact on the Company.

 

 

10.9.     Dividends Payable

 

During the quarter ended September June 30,2017, 2020, we accrued $14,000$13,000 in dividends payable to the holders of our 5% Preferred Stock, $15,000$13,000 in dividends payable to the holders of our Series 25% Preferred Stock and $8,000$7,000 in dividends payable to the holders of our Series 35% Preferred Stock. As of SeptemberJune 30, 2017, 2020, we have $411,000had $19,000 in accrued and unpaid dividends.

Delaware law provides that we may only pay dividends, outall of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. These dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock. Our CEO, CFO and one outside board member who are holders of our Series 2 and Series 3 Preferred Stockwhich have waived any possible late fee penalties. In addition to this late penalty, the holders of our Series 2 Preferred Stock and Series 3 Preferred Stock could elect to present us with written notice of our failure to pay dividends as scheduled, in which case we would have 45 days to cure such a breach. In the event that we failed to cure the breach, the holders of these shares of preferred stock would then have the right to require us to redeem their shares of preferred stock for a cash amount calculated in accordance with their respective certificates of designation. If we were required to redeem all shares of Series 2 Preferred Stock and Series 3 Preferred Stockbeen paid as of November 1, 2017, the aggregate redemption price we would owe would be $2.2 million.date of this Quarterly Report.

 

 

11. Other Income10.   Right-of-use Asset and Leasing Liabilities

 

On July 7, 2017, Under the new lease accounting standard, we have determined that we have leases for right-of-use (ROU) assets. We have both finance right-of-use assets and operating right-of-use assets with a related lease liability. Our finance lease right-of-use assets consist of computer hardware and a copying machine. Our operating lease right-of-use assets include our rental agreements for our offices in Richardson and San Marcos, CA. Both types of lease liabilities are determined by the net present value of total payments and are amortized over the life of the lease. Both types of lease obligations are designed to terminate with the last scheduled payment. All of the finance lease right-of-use assets have a three year life and are in various stages of completion. The Richardson operating lease liability has a life of four years and five months as of June 30, 2020. The San Marcos operating lease liability has a life of nine months as of June 30, 2020. The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of $1,553 thousand and a related lease liability of $1,744 thousand during the first quarter of 2019.

10

Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC 842 prospectively and elected the package of transition practical expedients that does not require reassessment of: (1) whether any existing or expired contracts are or contain leases, (2) lease classification and (3) initial direct costs. In addition, the Company has elected other available practical expedients to not separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of 12 months or less.

As the implicit rate is not readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.

Supplemental cash flow information includes operating cash flows related to operating leases. For the six months ended June 30, 2020 and 2019, the Company had $179 thousand and $88 thousand, respectively, in operating cash flows related to operating leases.

Schedule of Items Appearing on the Statement of Operations:

  

Three Months Ended

  

Six Months Ended

 
  

June 30, 2020

  

June 30, 2019

  

June 30, 2020

  

June 30, 2019

 

Operating expense:

                

Amortization expense – Finance ROU

 $11  $16  $21  $32 

Lease expense – Operating ROU

  82   83   165   162 

Other expense:

                

Interest expense – Finance ROU

 $  $1  $1  $2 

Future minimum lease obligations consisted of the following at June 30, 2020 (in thousands):

  

Operating

  

Finance

     

Period ending June 30,

 

ROU Leases

  

ROU Leases

  

Total

 

2021

 $363  $39  $402 

2022

  363   5   368 

2023

  375      375 

2024

  384      384 

2025

  159      159 

Thereafter

         
  $1,644  $44  $1,688 

Less Interest*

  (183

)

  (1

)

    
  $1,461  $43     

*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.

11

11.   PPP Loan

On March 27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which includes provision for a Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”). The PPP allows qualifying businesses to borrow up to $10 million calculated based on qualifying payroll costs. The loan is guaranteed by the federal government, and does not require collateral. On April 30, 2020 we entered into a salePPP Loan with Silicon Valley Bank effective April 30, 2020, pursuant to the PPP under CARES for $629,000. The PPP Loan matures on April 30, 2022 and bears interest at a rate of 1.0% per annum. Monthly amortized principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan funds were received on April 30, 2020. The PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP provides that (1) the use of PPP Loan amount shall be limited to certain IP addressesqualifying expenses, (2) 100 percent of the principal amount of the loan is guaranteed by the SBA and (3) an amount up to the full principal amount may qualify for loan forgiveness in accordance with the terms of CARES. We are not yet able to determine the amount that were not currently being usedmight be forgiven. As of June 30, 2020, the Company was in full compliance with all covenants with respect to the PPP Loan. The Company expects to use the full proceeds of the PPP loan in accordance with the provisions of CARES. As of June 30, 2020, the balance of the PPP Loan was $630,000, which includes $1.0 thousand in accrued interest.

Future minimum loan obligations consisted of the following at June 30, 2020 (in thousands):

Period ending June 30,

 

PPP Loan

 

2021

 $285 

2022

  356 

2023

   

2024

   

2025

   

Thereafter

   
  $641 

Less Interest*

  (11

)

  $630 

12.   Coronavirus Outbreak in the Company'sUnited States

Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results. The extent of the impact of COVID-19 on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted. A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and were may require additional cost and effort should our employees not required for be able to be physically on-premises.

13.   Subsequent Events.

As of the Company's future business plans.date of this Quarterly Report, all current shares of issued and outstanding preferred stock have been voluntarily converted, resulting in the issuance of a total of 1,004,249 newly issued shares of the Company’s common stock. The net proceeds from the saleaddition of these intellectual property assets werenewly issued shares has resulted in the amountdilution of $872,000 whicheach share of issued and outstanding common stock by a factor of 7.28%.  While the Company received on August 9, 2017. In addition, $56,000 was received on August 3, 2017 from the sale of an investment. The receiptelimination of these transactions had an immediate positive impactthree classes of preferred stock removes a number of the Company’s obligations to the holders of preferred stock (such as the obligation to pay continuing dividends) as well as a number of restrictions on the Company's liquidity position.Company’s activities (such as restrictions on certain capital raising and funding transactions), the addition of these newly issued shares combined with the fact that the Company’s common stock is thinly traded on the OTCQB Marketplace could cause an increase in selling volume, and result in a decline in the market price of the Company’s common stock.

On August 6, 2020, Anthony J. LeVecchio was appointed to the board of directors and to serve on the Company’s audit and compensation committees.

12

 


Item 2.2.                 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Statements

 

This Quarterly Report on Form 10-Q, including, without limitation, the section entitled “Management’s“Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements are generally accompanied by words such as “estimate,” “expect,” “believe,” “should,” “would,” “could,” “anticipate,” “may” or other words that convey uncertainty of future events or outcomes. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations, which we describe in more detail elsewhere in this Quarterly Report on Form 10-Q, in Part II Item 1A ”Risk Factors”, andas well as in our 20162019 Annual Report on Form 10-K, filed March 27, 2020, in Item 1A “Risk Factors” include, but are not limited to:

the uncertain ramifications related to the coronavirus outbreak;

our ability to successfully create, market, sell and distribute our new Shield product to a new and distinct customer base

our ability to produce and promote our new commercial product, Intrusion Shield, and market it through new sales channels to a new set of prospective customers;

 

 

insufficient cash to operate our business and inability to meet our liquidity requirements;

 

 

loss of revenues due to the failure of our newer products, Shield in particular, to achieve market acceptance;

 

 

our need to increase current revenue levels in order to achieve sustainable profitability;

our unavailability to make future borrowings under the CEO Note;

our ability to replace all or a portion of the borrowing capacity available to the Company under the CEO Note and whether any such terms would be available on terms acceptable to the Company, if at all;

our ability to raise funds through debt or equity offerings related to launching a commercial product;

 

 

concentration of our revenues from U.S. government entities or commercial customers and the possibility of loss of one of these customers and the unique risks associated with government customers;

 

 

our dependence on sales made through indirect channels;

our dependence on equity or debt financing provided primarily by our Chief Executive Officer under the CEO Note in order to meet our cash flow requirements;

the adverse effect that payment of accrued dividends on our preferred stock would have on our cash resources and the substantial dilution upon the conversion or redemption of our preferred stock;

the consequences of our inability to pay scheduled dividends on shares of our preferred stock;

the potentially detrimental impact that the conversion of preferred stock would have on the price of our common stock;

the ability of our preferred stockholders to hinder additional financing; and

 

 

the influence that our management and larger stockholders have over actions taken by the Company.

 

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. These forward-looking statements and other statements made elsewhere in this report are made in reliance on the Private Securities Litigation Reform Act of 1995. Any forward-looking statement you read in this Quarterly Report on Form 10-Q or our Annual Report on Form 10-K reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The section below entitled “Factors That May Affect Future Results of Operations” sets forth and incorporates by reference certain factors that could cause actual future results of the Company to differ materially from these statements.

 


13

 

Results of Operations

 

The following table sets forth, for the periods indicated, certain financial data as a percentage of net revenues. The period-to-period comparison of financial results is not necessarily indicative of future results.

 

 

Three Months Ended

  

Nine Months Ended

  

Three Months Ended

  

Six Months Ended

 
 

September 30, 2017

  

September 30, 2016

  

September 30, 2017

  

September 30, 2016

  

June 30, 2020

  

June 30, 2019

  

June 30, 2020

  

June 30, 2019

 

Total revenue

  100.0

%

  100.0

%

  100.0

%

  100.0

%

  100.0

%

  100.0

%

  100.0

%

  100.0

%

                                

Total cost of revenue

  43.9   38.2   40.8   35.7   39.3   39.6   40.5   39.9 
                                

Gross profit

  56.1   61.8   59.2   64.3   60.7   60.4   59.5   60.1 
                                

Operating expenses:

                                

Sales and marketing

  23.5   26.8   24.4   27.2   29.3   1.0   28.8   6.3 

Research and development

  36.7   31.9   37.6   40.7   54.8   7.4   48.1   6.7 

General and administrative

  14.4   18.4   17.9   20.0  

19.7

   8.0   16.9   9.0 

Operating income (loss)

  (43.1

)

  43.9   (34.3

)

  38.1 
                                

Operating loss

  (18.5

)

  (15.3

)

  (20.7

)

  (23.6

)

Interest income

  0.1      0.2    

Interest expense

  (0.2

)

  (0.2

)

  (0.1

)

  (0.6

)

                                

Other income

  55.3      19.4    

Interest expense, net

  (2.9

)

  (2.3

)

  (3.3

)

  (2.2

)

                

Income (loss) before income tax provision

  33.9   (17.6

)

  (4.6

)

  (25.8

)

Income (loss) before income tax provision

  (43.2

)

  43.7   (34.2

)

  37.5 
                                

Income tax provision

                        
                                

Net income (loss)

  33.9

%

  (17.6

)%

  (4.6

)%

  (25.8

)%

  (43.2

)%

  43.7

%

  (34.2

)%

  37.5

%

Preferred stock dividends accrued

  (2.1

)

  (2.2

)

  (2.2

)

  (2.2

)

  (2.0

)

  (0.8

)

  (1.9

)

  (0.9

)

                                

Net income (loss) attributable to common stockholders

  31.8

%

  (19.8

)%

  (6.8

)%

  (28.0

)%

  (45.2

)%

  42.9

%

  (36.1

)%

  36.6

%

 

 

  

Three Months Ended

  

Nine Months Ended

 
  

September 30, 2017

  

September 30, 2016

  

September 30, 2017

  

September 30, 2016

 

Domestic revenues

  100.0

%

  100.0

%

  100.0

%

  100.0

%

Export revenues

            
                 

Net revenues

  100.0

%

  100.0

%

  100.0

%

  100.0

%

  

Three Months Ended

  

Six Months Ended

 
  

June 30, 2020

  

June 30, 2019

  

June 30, 2020

  

June 30, 2019

 

Domestic revenues

  100.0

%

  100.0

%

  100.0

%

  100.0

%

Export revenues

            
                 

Net revenues

  100.0

%

  100.0

%

  100.0

%

  100.0

%

 

 

Net Revenues. Net revenues for the quarter and ninesix months ended SeptemberJune 30, 20172020 were $1.7 million and $4.8$3.5 million, respectively, compared to $1.6$4.0 million and $4.7$7.2 million for the same periods in 2016.2019. Product revenues increased $0.1decreased $2.3 million for the quarter ended SeptemberJune 30, 2017,2020, and increased $0.1$3.7 million for the ninesix months ended SeptemberJune 30, 20172020 compared to the same periods in 2016.2019. Decreased product revenues were primarily due to a decrease in sales of our TraceCop product line. TraceCop sales for the quarters ended SeptemberJune 30, 20172020 and 20162019 were $1.7$1.6 million and $1.6$4.0 million, respectively. Savant sales were $106 thousand for the quarter ended June 30, 2020 and were $29 thousand for the quarter ended SeptemberJune 30, 2017 and $22 thousand for the quarter ended September 30, 2016.2019.

 

Concentration of Revenues. Revenues from sales to various U.S. government entities totaled $1.5 million, or 90.6%91.0% of revenues, for the quarter ended SeptemberJune 30, 20172020 compared to $1.3$3.9 million, or 78.4%91.3% of revenues, for the same period in 2016.2019. Revenues from sales to various U.S. government entities totaled $3.8$2.8 million, or 80.2%80.8% of revenues, for the ninesix months ended SeptemberJune 30, 20172020 compared to $3.3$6.4 million, or 70.0%89.2% of revenues, for the same period in 2016.2019. Sales to commercial customers totaled 9.4%9.0% of total revenue for the thirdsecond quarter of 20172020 compared to 21.6%8.7% of total revenue for the thirdsecond quarter of 2016.2019. During the thirdsecond quarter of 2017, approximately 6.2%2020 and 2019, no individual commercial customer had revenues over 10.0% of total revenue was attributable to one commercial customer compared to approximately 18.9% to one commercial customer in the third quarter of 2016.revenue. Although we expect our concentration of revenues to vary among customers in future periods depending upon the timing of certain sales, we anticipate that sales to government customers will continue to account for a significant portion of our revenues in future periods. Sales to the government present risks in addition to those involved in sales to commercial customers which could adversely affect our revenues, including, without limitation, potential disruption to appropriation and spending patterns and the government’s reservation of the right to cancel contracts and purchase orders for its convenience. Although we do not anticipate that any of our revenues with government customers will be renegotiated, a large number of cancelled or renegotiated government orders could have a material adverse effect on our financial results. Currently, we are not aware of any proposed cancellation or renegotiation of any of our existing arrangements with government entities and, historically, government entities have not cancelled or renegotiated orders which had a material adverse effect on our business.

 


14

 

Gross Profit. Gross profit was $0.9$1.0 million or 56.1%60.7% of net revenues for the quarter ended SeptemberJune 30, 2017,2020, compared to $1.0$2.4 million or 61.8%60.4% of net revenues for the quarter ended SeptemberJune 30, 2016.2019. Gross profit was $2.8$2.1 million or 59.2%59.5% of net revenues for the ninesix months ended SeptemberJune 30, 20172020 compared to $3.0$4.3 million or 64.3%60.1% of net revenues for the ninesix months ended SeptemberJune 30, 2016.2019. Gross profit on product revenues trended from 59.5% of net revenues for the quarter and ninesix months ended SeptemberJune 30, trended from 61.8% and 64.3%, respectively, in 20162020 to 56.1% and 59.2%, respectively, in 201760.1% of net revenues for the six months ended June 30, 2019, mainly due to a change inTraceCop/Savant product mix and slightly higher labor cost associated with TraceCop sales.mix. Gross profit as a percentage of net revenues is impacted by several factors, including shifts in product mix, changes in channels of distribution, revenue volume, pricing strategies, and fluctuations in revenues of integrated third-party products.

 

Sales and Marketing. Sales and marketing expenses remained constant at $0.4increased to $0.5 million for the three monthsquarter ended SeptemberJune 30, 2017 and 2016.2020 compared to $46 thousand for the same period in 2019. Sales and marketing expenses decreasedincreased to $1.2$1.0 million for the ninesix months ended SeptemberJune 30, 20172020 compared to $1.3$0.5 million for the same period in 2016.2019. Sales and marketing expenses may vary in the future. Sales and marketing expenses increased compared to the comparable periods last year due to increases in labor and expenses and the Company was able to collect payment of $200 thousand from a customer related expense in 2018 that reduced expense in 2019. We believe that these costs will increase through the end of 2017,2020 due to increases associated with increases in revenue.increased marketing expense related to the Shield launch.

 

Research and Development. Research and development expenses increased to $0.6$0.9 million for the quarter ended SeptemberJune 30, 20172020 compared to $0.3 million for the same period in 2019. Research and development expenses increased to $1.7 million for the six months ended June 30, 2020 compared to $0.5 million for the same period in 2016. Research2019. The increase in research and development expenses decreasedexpense was due partly to $1.8 million forincreased costs related to the nine months ended September 30, 2017 compareddevelopment of our Intrusion Shield product as well as an increase in labor expense due to $1.9 million for the same period in 2016.less direct labor required on existing projects. Research and development costs are expensed in the period in which they are incurred. Research and development expenses may vary in the future; however, we believe that these costs will remain relatively constant through the endmainly dependent on levels of 2017, although expenses may be increased relativeresearch and development labor expense charged to increases in revenue.projects.

 

General and Administrative. General and administrative expenses decreased to $0.2 million for the quarters ended September 30, 2017 compared to $0.3 million for the same period in 2016. General and administrative expenses remained constant at $0.9$0.3 million for the ninequarters ended June 30, 2020 and 2019. General and administrative expenses decreased to $0.6 million for the six months ended June 30, 2020 compared to $0.7 million for September 30, 2017 and 2016.the same period in 2019. It is expected that general and administrative expenses will remain relatively constant throughout the remainder of 2017,2020, although expenses may be increased relativedue to increases in revenue.

Other Income.On July 7, 2017, the Company entered intoincreased expenses related to a sale of certain IP addresses that were not currently being used in the Company's business operations and were not required for the Company's future business plans. The net proceeds from the sale of these intellectual property assets were in the amount of $872,000 which the Company received on August 9, 2017. In addition, $56,000 was received on August 3, 2017 from the sale of an investment.new product launch.

 

Interest. Net interestInterest expense increaseddecreased to $49$2 thousand for the quarter ended SeptemberJune 30, 20172020 compared to $36$9 thousand for the same period in 2016. Net interest2019. Interest expense increaseddecreased to $157$2 thousand for the ninesix months ended SeptemberJune 30, 20172020 compared to $102$44 thousand for the same period in 2016. The increase in interest2019. Interest expense was primarilydecreased due to an increasedecreased amount of Loan Payable to Officer culminating in our repayment of the shareholder loan amount from our CEO and an increasebalance in the prime rate by 0.25% in June. Net interestMay 2019. Interest expense maywill vary in the future based on our level of borrowing, which will be affected by our cash flow operatingand borrowing needs. Interest income increased to $1 thousand for the quarter ended June 30, 2020 compared to none for the same period in 2019. Interest income increased to $7 thousand for the six months ended June 30, 2020 compared to none for the same period in 2019. This is attributable to investing extra cash in money market accounts and capital expenditures.getting better interest rates.

 

Liquidity and Capital Resources

 

Our principal source of liquidity at SeptemberJune 30, 2017,2020 was approximately $263 thousand$2.9 million of cash and cash equivalents. At SeptemberJune 30, 2017,2020, we had a working capital deficiency of $1.0$2.4 million compared to a $1.0$1.4 million deficiency at SeptemberJune 30, 2016.2019.

 


Net cash provided by operations for the nine months ended September 30, 2017, was $274 thousand due to the following sources of cash and non-cash items: $263 thousand increase in deferred revenue, $168 thousand increase in accounts payable and accrued expenses, $40 thousand decrease in prepaid expenses and other assets, $15 thousand decrease in Inventories, $106 thousand in amortization expense of capital leases, $53 thousand in depreciation expense, $24 thousand in penalties and waived penalties on dividends, and $16 thousand in stock-based compensation. This was partially offset by a net operating loss of $221 thousand, $56 thousand gain on sale of investment and a $134 thousand increase in accounts receivable. Net cash used in operations for the ninesix months ended SeptemberJune 30, 2016,2020 was $606 thousand$1.0 million due primarily to a net loss of $1.2 million and the following useuses of cash: a $8$352 thousand decrease in deferred revenue, a $234 thousand increase in prepaid expenses and other assets, and a $64 thousand decrease in accounts receivablepayable and a $7 thousand decrease in Inventories.accrued expenses. This was partially offset by the following sourcesprovisions of cash and non-cash items: $236a $499 thousand decrease in accounts receivable, $124 thousand in noncash lease costs, $107 thousand in depreciation and amortization expense, and $74 thousand in stock-based compensation. Net cash provided by operations for the six months ended June 30, 2019 was $2.3 million due primarily to a net income of $2.7 million and the following provisions of cash and non-cash items: $304 thousand in noncash lease costs, a $179 thousand increase in deferred revenue, $39 thousand increase in accounts payable and accrued expenses, a $31 thousand decrease in prepaid expenses and other assets, $71$86 thousand in depreciation expense, $147 thousand inand amortization expense, of capital leases, $82$14 thousand in stock-based compensation, and $13$6 thousand in penalties and waived penalties on dividends. This was partially offset by a $738 thousand increase in accounts receivable, a $234 thousand increase in prepaid expenses and other assets, and a $66 thousand decrease in accounts payable and accrued expenses. Future fluctuations in inventory balances, accounts receivable and accounts payable will be dependent upon several factors, including, but not limited to, quarterly sales volumes and timing of invoicing, and the accuracy of our forecasts of product demand and component requirements.

 

Net cash provided byused in investing activities for the ninesix months ended SeptemberJune 30, 2017,2020, was $43 thousand due to $56 thousand in proceeds from sale of investment offset by $13$62 thousand for net purchases of property and equipment, compared to $41$168 thousand for net purchases of property and equipment for cash used in investing activities for the ninesix months ended SeptemberJune 30, 2016.2019 for net purchases of property and equipment.

 

15

Net cash used by financing activities for the nine months ended September 30, 2017, was $118 thousand due to $1.6 million in payments to the loan by an officer, and $109 thousand payment on the principal of capital leases. This was offset by: proceeds from a loan by an officer of $1.58 million and $11 thousand in proceeds from the exercise of stock options.

Net cash provided by financing activities in 20162020 was $755 thousand$0.6 million generated primarily due toby proceeds from a PPP loan by an officer of $805 thousand. Other provisions were$0.6 million and proceeds from the line-of-credit of $364 thousand and $99 thousand from the exercise of stock options.options of $85 thousand. This was directly offset by the following uses of cash: $364payments for preferred stock dividends of $67 thousand, in payments to the line-of-credit and $149 thousand payment on principal of finance right-of-use leases of $21 thousand. Net cash used in financing activities in 2019 was $2.3 million with payments on capital leases.the loan from an officer of $1.8 million, payments for preferred stock dividends of $644 thousand, and payment on principal of finance right-of-use leases of $31 thousand. This was directly offset by the following provisions of cash: proceeds from exercise of stock options of $226 thousand.

 

At SeptemberJune 30, 2017,2020, the Company did not have any material commitments for capital expenditures.

 

During the ninesix months ended SeptemberJune 30, 2017,2020, the Company funded its operations through the use of cash and cash equivalents sale of certain assets (see note 11) and advances under the CEO Note.

equivalents. As of SeptemberJune 30, 2017,2020, we had cash and cash equivalents of approximately $263,000, up$2,872,000, down from approximately $64,000$3,334,000 as of December 31, 2016.2019. We generatedhad a net incomeloss of $568,000$715,000 for the quarter ended SeptemberJune 30, 20172020 compared to a net lossincome of $280,000$1,758,000 for the quarter ended SeptemberJune 30, 2016. We also received one-time revenue during our third quarter in the amount $872,000, recognized as other income, which increased our net income significantly.  As of September 30, 2017, in addition to cash and cash equivalents of $263,000, we had $835,000 funding available from a promissory note to borrow up to $3.7 million from G. Ward Paxton, the Company’s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources.2019. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months.

As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are available on terms acceptable to the Company, if at all (the “Potential Replacement Funding Facility”).

We expect to fund our operations through anticipated Company profits, the Potential Replacement Funding Facility, and borrowings from the Company’s CEO, and possiblypossible additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly.debt. Any equity or debt financings,options, if available at all, may be on terms which are not favorable to us and, in the case of any potential equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the upcoming year,future, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

We may explore the possible acquisitions of businesses, products and technologies that are complementary to our existing business. We are continuing to identify and prioritize additional security technologies, which we may wish to develop, either internally or through the licensing, or acquisition of products from third parties. While we may engage from time to time in discussions with respect to potential acquisitions, there can be no assurances that any such acquisitions will be made or that we will be able to successfully integrate any acquired business. In order to finance such acquisitions and working capital it may be necessary for us to raise additional funds through public or private financings. Any equity or debt financings, if available at all, may be on terms, which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders.

 

Item 4.

CONTROLS AND PROCEDURES

 

We maintain “disclosure controls and procedures,” as defined in Rule 13a-15(e)13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

 

Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of SeptemberJune 30, 2017,2020, and concluded that the disclosure controls and procedures were effective.

 

Our management, with the participation of our principal executive officer and principal financial officer, evaluated our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) as of December 31, 2016,2019, and concluded that there have not been any changes in our internal control over financial reporting that occurred during the quarter ended SeptemberJune 30, 2017,2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 


PART II – OTHER INFORMATION

 

Item 1.1.

LEGAL PROCEEDINGS

 

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise will not have such a material impact in the future.

 

16

 

Item 1A.

Item 1A.          RISK FACTORS

 

Factors That May Affect Future Results of Operations

 

We are providing the following information regarding changes that have occurred to previously disclosed risk factors from our Annual Report on Form 10-K for the year ended December 31, 2016.2019. In addition to the other information set forth below and elsewhere in this report, you should consider the factors discussed under the heading “Risk Factors” in our Form 10-K for the year ended December 31, 20162019 filed on March 27, 2020 and the previous Quarterly Reports filed onin our Form 10-Q for the periodsquarter ended on March 31, 2017 and June 30, 2017.2020 filed on May 15, 2020. The risks described in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

 

WUncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of the federal, state, and local governmental entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.

            We have a concentration of customers that are federal, state, and local governmental entities.  Such entities will be required to allocate resources and adjust budgets to accommodate potential contingencies related to the effects of the coronavirus and measures required to be put in place to prevent and contain contamination of the virus.  These uncertainties have resulted in certain of our customers delaying budgeted expenditures or re-allocating resources that would result in a decrease in orders from these customers, and the possibility that other customers may follow suit in the weeks and months to come.  Any such decrease in orders from these customers could cause a material adverse effect on our operations and financial results.

eA material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and may require additional cost and effort should our employees not be able to be physically on-premises.

Should we experience periods where it is not prudent for some or all of our employees to be physically present on-site, we may not have the benefit of the time and skills of such employees or we may be required to adjust our current business operations and processes to permit some or all of our employees at any one of our locations to work remotely in order to avoid the potential spread of the virus.  We can offer no assurances that these adjustments would not cause material disruptions to our daily operations, require us to expend our time, energy and resources to make necessary adjustments, and may result in a material adverse effect on our sales, research and development and other critical areas of our business model.

Our common stock may experience volatility in trading or loss in value as a result of the effects of the coronavirus on the US and global economies.

            Uncertainties surrounding the effects of the coronavirus on the US and global economies has resulted in an increase in volatility and violent drops in the value of publicly traded securities, including the trading in our common stock.  We can offer no assurances that these effects are temporary or that any losses that are incurred as a result of these uncertainties will be regained if and when this crisis has passed.  As a result, the value of our stock remains subject to such volatility and potential loss of market value.

We may be unable to successfully produce and promote our new commercial product, Intrusion Shield, and market it through new sales channels to a new set of prospective customers.

We anticipate significant resources will be required in order to complete product development of Intrusion Shield, including the time, attention, and focus of our senior management and our research and development team, coordination of new marketing strategies highlighting this new product offering and promoting it through new and expanded sales channels to a wider audience of prospective customers than we have historically marketed and sold our products and services. In addition, significant financial resources will be required to successfully manage and implementation this new product rollout. This could result in diversion of those resources from critical areas of our company operations and a potential strain on our liquidity and ability to meet our current and these anticipated increases in our cash-flow needs. We may need to explore possible funding sources in order to successfully complete this project, including, without limitation, exploring options for meeting those needs through equity investment and/or debt financing which may not be on terms favorable to the Company and its stockholders (if available at all), and in the instance where additional equity securities may be issued, result in significant dilution to our existing stockholders.

17

We could experience damage to our reputation in the cyber-security industry in the event that our Intrusion Shield product fails to perform as expected, to meet our customers’ needs, or to achieve market acceptance.

Our reputation in the industry as a leading provider of entity identification, data mining, and advanced persistent threat detection products may be harmed, perhaps significantly, in the event that our new Intrusion Shield fails to perform as we expect it to. If Shield does not perform as we expect, if we experience product delivery delays, or if our customers do not perceive the benefits of purchasing and using Shield as part of their comprehensive cyber-security solution, our position as a leader in this technology space may be damaged and could affect customers, as well as potential customers, willingness to purchase our other products that function separately from our Intrusion Shield. Any reputational damage could result in a decrease in orders for all of our products, the loss of current customers, and a decrease in our overall revenues which could in turn have a material adverse effect on our results of operation.

We must expend time and resources addressing potential cyber-security risk, and any breach of our information security safeguards could have a material adverse effect on the Company.

            The threat of cyber-attacks requires additional time and money to be expended in efforts to prevent any breaches of our information security protocols.  However, we can provide no assurances that we can prevent any and all such attempts from being successful, which could result in expenses to address and remediate such breaches as well as potentially losing the confidence of our customers who depend upon our services to prevent and mitigate such attacks on their respective business.  Should a material breach of our information security systems occur, it would likely have a material adverse impact on our business operations, our customer relations, and our current and future sales prospects, resulting in a significant loss of revenue.

We may not have sufficient cash to operate our business.business and may not be able to maintain future liquidity requirements. Additional debt and equity offerings to fund future operations may not be available and, if available, may significantly dilute the value of our currently outstanding common stock.

 

As of SeptemberJune 30, 2017,2020, we had cash and cash equivalents of approximately $263,000, up$2,872,000, down from approximately $64,000$3,334,000 as of December 31, 2016.2019. We generatedhad a net incomeloss of $568,000$715,000 for the quarter ended SeptemberJune 30, 20172020 compared to a net lossincome of $280,000$1,758,000 for the quarter ended SeptemberJune 30, 2016. We also received one-time revenue during our third quarter in the amount $872,000, recognized as other income, which increased our net income significantly.  As of September 30, 2017, in addition to cash and cash equivalents of $263,000, we had $835,000 funding available from a promissory note to borrow up to $3.7 million from G. Ward Paxton, the Company’s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources.2019. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are available on terms acceptable to the Company, if at all (the “Potential Replacement Funding Facility”).

We expect to fund our operations through anticipated Company profits, the Potential Replacement Funding Facility, and borrowings from the Company’s CEO, and possiblypossible additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly.debt. Any equity or debt financings,options, if available at all, may be on terms which are not favorable to us and, in the case of any potential equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the upcoming year,future, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

 

We had a net incomeloss of $5680.7 milliothousandn for the quarter ended SeptemberJune 30, 2017,2020, and we have an accumulated deficit of $651.76.0 million as of SeptemberJune 30, 2017.2020. To achieveimprove our annualfinancial performance, we must increase revenue levels profitability, we must generate increasedof our existing product offerings and/or increase our revenue levels.through the introduction and sale of our new Shield product.

 

For the quarter ended SeptemberJune 30, 2017,2020, we generatedhad a net incomeloss of $568 thousand$0.7 million and had an accumulated deficit of approximately $61.7$56.0 million as of June 30, 2020, compared to a net lossincome of $280 thousand$1.8 million for the quarter ended SeptemberJune 30, 20162019 and an accumulated deficit of approximately $61.2 million.$54.8 million at December 31, 2019. We need to sustain greaterincrease current revenue levels from the sales of our currently existing products or through the addition of sales of our new Shield product if we are to achieve annualregain profitability. If we are unable to achieve these revenue levels, losses could happencontinue for the near term and possibly longer, and we may not sustainregain profitability or generate positive cash flow from operations.operations in the future.

 

A large percentage of our revenues are received from U.S. government entities/resellers, and the loss of any one of these customers could reduce our revenues and materially harm our business and prospects.

 

A large percentage of our revenues result from sales to U.S. government entities/resellers. If we were to lose one or more of these key relationships, our revenues could decline and our business and prospects may be materially harmed. We expect that even if we are successful in developing relationships with non-governmental customers, our revenues will continue to be concentrated among government entities. For the quarter ended SeptemberJune 30, 2017,2020, sales to U.S. government entities/resellers collectively accounted for 90.6%91.0% of our revenues, compared to 78.4%91.3% for the comparable period in 2016.2019. The loss of any of these key relationships may send a negative message to other U.S. government entities or non-governmental customers concerning our product offering. We cannot assure you that U.S. government entities will be customers of ours in future periods or that we will be able to diversify our customer portfolio to adequately mitigate the risk of loss of any of these customers.

 


18

 

A large percentageAlmost all of our revenues are from one product line with a limited number of customers, and the decrease of revenue from sales of this product line could materially harm our business and prospects. Timeliness of orders from customers may cause volatility in growth.

 

A large percentageAlmost all of our revenues result from sales of ourone security product line. TraceCop revenues were $1.6 million for the quarter ended June 30, 2020, compared to $4.0 million for the second quarter 2019. Savant revenues were $29increased to $106 thousand for the quarter ended SeptemberJune 30, 20172020, compared to $22$29 thousand for the same period in 2016. TraceCop revenues were $1.7 million for thesecond quarter ended September 30, 2017, compared to $1.6 million for the same quarter in 2016. No individual commercial customer in the third quarter of 2017 exceeded 10% of total revenues compared to one customer at 18.9% for the same period in 2016 that exceeded 10% of total revenues for that quarter.2019. If sales of this key product line were to decrease, our revenues could decline and our business and prospects may be materially harmed. No individual commercial customer in the second quarter of 2020 and 2019 had over 10.0% of total revenue.

 

We are highly dependent on sales made through indirect channels, the loss of which would materially adversely affect our operations.

 

We derived 92.1%54.0% of revenue in the thirdsecond quarter of 20172020 through indirect channels of mainly government resellers, compared to 79.8%91.3% of our revenues in the quarter ended SeptemberJune 30, 2016.2019. We must continue to expand our sales through these indirect channels in order to increase our revenues. We cannot assure you that our products will gain market acceptance in these indirect sales channels or that sales through these indirect sales channels will increase our revenues. Further, many of our competitors are also trying to sell their products through these indirect sales channels, which could result in lower prices and reduced profit margins for sales of our products.

 

You will experience substantial dilution upon the conversion or redemption oexercise of stock options currently outstanding.f the shares of preferred stock that we issued in our private placements or in the event we raise additional funds through the issuance of new shares of our common stock or securities convertible or exercisable into shares of common stock.

 

On November 1, 2017,July 31, 2020, we had 12,797,836 shares of common stock outstanding. Upon conversion of all outstanding shares of preferred stock, we will have 13,865,279 shares of common stock outstanding, approximately an 8.3% increase in the number of shares of our common stock outstanding.

In addition, management may issue additional shares of common stock or securities exercisable or convertible into shares of common stock in order to finance our continuing operations. Any future issuances of such securities would have additional dilutive effects on the existing holders of our Common Stock.

Further, the occurrence of certain events could entitle holders of our Series 2 Preferred Stock and Series 3 Preferred Stock to require us to redeem their shares for a certain number of shares of our common stock. Assuming (i) we have paid all liquidated damages and other amounts to the holders, (ii) paid all outstanding dividends, (iii) a volume weighted average price of $0.23, which was the ten-day volume weighted average closing price of our common stock on October 27, 2017, and (iv) our 12,797,836 shares of common stock outstanding on October 27, 2017, upon exercise of their redemption right by the holders of the Series 3 Preferred Stock and the Series 2 Preferred Stock, we would be obligated to issue approximately 1,215,000 shares of our common stock. This would represent an increase of approximately 9.5% in the number of shares of our common stock as of October 27, 2017.

The conversion of preferred stock we issued in the private placements may cause the price of our common stock to decline.

The holders of the shares of our 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of November 1, 2017, 800,000 shares of our 5% Preferred Stock had converted into 1,272,263 shares of common stock and 200,000 shares of our 5% preferred stock, convertible into 318,065 shares of common stock, remain outstanding.

The holders of the shares of Series 2 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of November 1, 2017, 605,200 shares of Series 2 Preferred Stock had converted into 605,200 shares of common stock and 460,000 shares of Series 2 5% preferred stock remain outstanding.

The holders of the shares of Series 3 5% Preferred Stock may freely convert their shares of Series 3 Preferred Stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of November 1, 2017, 275,230 shares of Series 3 Preferred Stock had converted into 275,230 shares of common stock and 289,377 shares of Series 3 5% preferred stock remain outstanding.

For the four weeks ended on October 27, 2017, the average daily trading volume of our common stock on the OTCQB was 2,011 shares. Consequently, if holders of preferred stock elect to convert their remaining shares and sell a material amount of their underlying shares of common stock on the open market, the increase in selling activity could cause a decline in the market price of our common stock. Furthermore, these sales, or the potential for these sales, could encourage short sales, causing additional downward pressure on the market price of our common stock.


You will experience substantial dilution upon the exercise of stock optionscurrently outstanding.

On November 1, 2017, we had 12,797,83613,792,030 shares of common stock outstanding.  Upon the exercising of current options exercisable at or below the exercise price of $1.10,$4.75, we willwould have approximately 14,905,00014,546,533 shares of common stock outstanding, an 18.0%a 5.5% increase in the number of shares of our common stock outstanding.

 

Our management and larger stockholders exercise significant control over our company and have the ability to approve or take actions that may be adverse to your interests.

 

As of November 1, 2017,the date of this Quarterly Report, our executive officers directors and preferred stockholdersdirectors beneficially own approximately 29%28% of our voting power.  In addition, other related non-affiliate parties control approximately 30%35% of voting power.  As a result, these stockholders will be able to exercise significant control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, which could delay or prevent someone from acquiring or merging with us.  These stockholders may use their influence to approve or take actions that may be adverse to the interests of holders of our Common Stock.  Further, we contemplate the possible issuance of shares of our Common Stock or of securities exercisable or convertible into shares of our Common Stock in the future to our Chief Executive Officer, and Chief Financial Officer.Officer and Senior Vice President.  Any such issuance will increase the percentage of stock our Chief Executive Officer, Chief Financial Officer, Senior Vice President and our management group beneficially holds.

 

Item 6.6.

Exhibits

 

The following Exhibits are filed with this report form 10-Q:

 

31.1

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act.

31.2

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act.

32.1

Certification Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

 


19

 

S I G N A T U R E S

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

INTRUSION INC.

 
   

Date: August 13, 2020

        /s/ Jack B. Blount

 

Date: November 14, 2017

 

/s/ G. Ward PaxtonJack B. Blount

 
 

G. Ward Paxton

Chairman,Director, President & Chief Executive Officer

 
 

(Principal Executive Officer)

 
   
   

Date: November 14, 2017August 13, 2020

/s/        /s/ Michael L. Paxton

 
 
 

Michael L. Paxton

 
 

Chairman, Vice President, Chief Financial Officer,
Treasurer & Secretary

 
Treasurer & Secretary
 

(Principal Financial & Accounting Officer)

 

 

16

20